Loading organizations...
Loading organizations...
Biotechnology company developing S-Adenosyl Methionine supplements.
MSI Methylation Sciences has raised $48.4M across 2 funding rounds.
MSI Methylation Sciences has raised $48.4M in total across 2 funding rounds.
MSI Methylation Sciences has raised $48.4M in total across 2 funding rounds.
MSI Methylation Sciences's investors include Quark Venture, Gunnar Weikert, BC Advantage Funds, Working Opportunity Fund.
MSI Methylation Sciences has raised $48.4M across 2 funding rounds. Most recently, it raised $30.0M Other Equity in October 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 6, 2016 | $30.0M Other Equity | Quark Venture | |
| Sep 29, 2011 | $18.4M Series A | Gunnar Weikert | BC Advantage Funds, Working Opportunity Fund |